Long-term outcome of human leukocyte antigen mismatching in liver transplantation

Results of the National institute of diabetes and digestive and kidney diseases liver transplantation database

Vijayan Balan, Kris Ruppert, A. Jake Demetris, Tatiana Ledneva, Rene J. Duquesnoy, Katherine M. Detre, Yuling L. Wei, Jorge Rakela, Daniel Francis Schafer, John P. Roberts, James E. Everhart, Russell H. Wiesner

Research output: Contribution to journalArticle

54 Citations (Scopus)

Abstract

A perfect or nearly perfect human leukocyte antigen (HLA) match has been associated with better immediate and long-term survival of diseased donor kidney transplants. However, the effect of HLA matching for hepatic allografts remains poorly defined. Using data from the National Institutes of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database, we investigated the association between HLA mismatches and hepatic allograft survival, disease recurrence, and immunosuppression interactions. A, B, and DR loci were used to calculate total mismatch scores of 0 (no mismatches in any loci) to 6 (mismatches in all loci). Seven hundred ninety-nine adults (male, 55%; fcmale, 45%) underwent 883 liver transplants. The 10-year graft survival according to total mismatch score was as follows: 0-2, 60%; 3-4, 54%; and 5-6, 57%. There was a negative effect of mismatching at the A locus on patient survival, with shorter survival for patients with 1 or 2 mismatches compared with 0 mismatches [P = 0.05, hazard ratio (HR) = 1.6]. Patients on tacrolimus with 1 or 2 mismatches at B or DR loci appeared to have increased rates of patient and graft survival compared to patients with 0 mismatches, with the appearance of a protective effect of tacrolimus (HR = 0.67). The cffect of HLA mismatching was more pronounced on certain disease recurrences. DR-locus mismatch increased recurrence of autoimmune hepatitis (P = 0.01, HR = 4.2) and primary biliary cirrhosis (P = 0.04, HR = 2). Mismatch in the A locus was associated with more recurrence of hepatitis C virus (P = 0.01, HR = 1.6) and primary sclerosing cholangitis (P = 0.03, HR = 2.9). Conclusion: Mismatching at the A locus decreases patient survival in liver transplant recipients, and mismatching at the DR and A loci affects recurrence of autoimmune liver diseases and hepatitis C, respectively.

Original languageEnglish (US)
Pages (from-to)878-888
Number of pages11
JournalHepatology
Volume48
Issue number3
DOIs
StatePublished - Sep 1 2008

Fingerprint

National Institute of Diabetes and Digestive and Kidney Diseases (U.S.)
HLA Antigens
Liver Transplantation
Databases
Recurrence
Autoimmune Hepatitis
Survival
Liver
Tacrolimus
Graft Survival
Allografts
Transplants
Sclerosing Cholangitis
Biliary Liver Cirrhosis
Kidney Diseases
Hepatitis C
Hepacivirus
Immunosuppression
Autoimmune Diseases
Liver Diseases

ASJC Scopus subject areas

  • Hepatology

Cite this

Long-term outcome of human leukocyte antigen mismatching in liver transplantation : Results of the National institute of diabetes and digestive and kidney diseases liver transplantation database. / Balan, Vijayan; Ruppert, Kris; Demetris, A. Jake; Ledneva, Tatiana; Duquesnoy, Rene J.; Detre, Katherine M.; Wei, Yuling L.; Rakela, Jorge; Schafer, Daniel Francis; Roberts, John P.; Everhart, James E.; Wiesner, Russell H.

In: Hepatology, Vol. 48, No. 3, 01.09.2008, p. 878-888.

Research output: Contribution to journalArticle

Balan, V, Ruppert, K, Demetris, AJ, Ledneva, T, Duquesnoy, RJ, Detre, KM, Wei, YL, Rakela, J, Schafer, DF, Roberts, JP, Everhart, JE & Wiesner, RH 2008, 'Long-term outcome of human leukocyte antigen mismatching in liver transplantation: Results of the National institute of diabetes and digestive and kidney diseases liver transplantation database', Hepatology, vol. 48, no. 3, pp. 878-888. https://doi.org/10.1002/hep.22435
Balan, Vijayan ; Ruppert, Kris ; Demetris, A. Jake ; Ledneva, Tatiana ; Duquesnoy, Rene J. ; Detre, Katherine M. ; Wei, Yuling L. ; Rakela, Jorge ; Schafer, Daniel Francis ; Roberts, John P. ; Everhart, James E. ; Wiesner, Russell H. / Long-term outcome of human leukocyte antigen mismatching in liver transplantation : Results of the National institute of diabetes and digestive and kidney diseases liver transplantation database. In: Hepatology. 2008 ; Vol. 48, No. 3. pp. 878-888.
@article{2ed46656407e4d52bb836d52ebffaf38,
title = "Long-term outcome of human leukocyte antigen mismatching in liver transplantation: Results of the National institute of diabetes and digestive and kidney diseases liver transplantation database",
abstract = "A perfect or nearly perfect human leukocyte antigen (HLA) match has been associated with better immediate and long-term survival of diseased donor kidney transplants. However, the effect of HLA matching for hepatic allografts remains poorly defined. Using data from the National Institutes of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database, we investigated the association between HLA mismatches and hepatic allograft survival, disease recurrence, and immunosuppression interactions. A, B, and DR loci were used to calculate total mismatch scores of 0 (no mismatches in any loci) to 6 (mismatches in all loci). Seven hundred ninety-nine adults (male, 55{\%}; fcmale, 45{\%}) underwent 883 liver transplants. The 10-year graft survival according to total mismatch score was as follows: 0-2, 60{\%}; 3-4, 54{\%}; and 5-6, 57{\%}. There was a negative effect of mismatching at the A locus on patient survival, with shorter survival for patients with 1 or 2 mismatches compared with 0 mismatches [P = 0.05, hazard ratio (HR) = 1.6]. Patients on tacrolimus with 1 or 2 mismatches at B or DR loci appeared to have increased rates of patient and graft survival compared to patients with 0 mismatches, with the appearance of a protective effect of tacrolimus (HR = 0.67). The cffect of HLA mismatching was more pronounced on certain disease recurrences. DR-locus mismatch increased recurrence of autoimmune hepatitis (P = 0.01, HR = 4.2) and primary biliary cirrhosis (P = 0.04, HR = 2). Mismatch in the A locus was associated with more recurrence of hepatitis C virus (P = 0.01, HR = 1.6) and primary sclerosing cholangitis (P = 0.03, HR = 2.9). Conclusion: Mismatching at the A locus decreases patient survival in liver transplant recipients, and mismatching at the DR and A loci affects recurrence of autoimmune liver diseases and hepatitis C, respectively.",
author = "Vijayan Balan and Kris Ruppert and Demetris, {A. Jake} and Tatiana Ledneva and Duquesnoy, {Rene J.} and Detre, {Katherine M.} and Wei, {Yuling L.} and Jorge Rakela and Schafer, {Daniel Francis} and Roberts, {John P.} and Everhart, {James E.} and Wiesner, {Russell H.}",
year = "2008",
month = "9",
day = "1",
doi = "10.1002/hep.22435",
language = "English (US)",
volume = "48",
pages = "878--888",
journal = "Hepatology",
issn = "0270-9139",
publisher = "John Wiley and Sons Ltd",
number = "3",

}

TY - JOUR

T1 - Long-term outcome of human leukocyte antigen mismatching in liver transplantation

T2 - Results of the National institute of diabetes and digestive and kidney diseases liver transplantation database

AU - Balan, Vijayan

AU - Ruppert, Kris

AU - Demetris, A. Jake

AU - Ledneva, Tatiana

AU - Duquesnoy, Rene J.

AU - Detre, Katherine M.

AU - Wei, Yuling L.

AU - Rakela, Jorge

AU - Schafer, Daniel Francis

AU - Roberts, John P.

AU - Everhart, James E.

AU - Wiesner, Russell H.

PY - 2008/9/1

Y1 - 2008/9/1

N2 - A perfect or nearly perfect human leukocyte antigen (HLA) match has been associated with better immediate and long-term survival of diseased donor kidney transplants. However, the effect of HLA matching for hepatic allografts remains poorly defined. Using data from the National Institutes of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database, we investigated the association between HLA mismatches and hepatic allograft survival, disease recurrence, and immunosuppression interactions. A, B, and DR loci were used to calculate total mismatch scores of 0 (no mismatches in any loci) to 6 (mismatches in all loci). Seven hundred ninety-nine adults (male, 55%; fcmale, 45%) underwent 883 liver transplants. The 10-year graft survival according to total mismatch score was as follows: 0-2, 60%; 3-4, 54%; and 5-6, 57%. There was a negative effect of mismatching at the A locus on patient survival, with shorter survival for patients with 1 or 2 mismatches compared with 0 mismatches [P = 0.05, hazard ratio (HR) = 1.6]. Patients on tacrolimus with 1 or 2 mismatches at B or DR loci appeared to have increased rates of patient and graft survival compared to patients with 0 mismatches, with the appearance of a protective effect of tacrolimus (HR = 0.67). The cffect of HLA mismatching was more pronounced on certain disease recurrences. DR-locus mismatch increased recurrence of autoimmune hepatitis (P = 0.01, HR = 4.2) and primary biliary cirrhosis (P = 0.04, HR = 2). Mismatch in the A locus was associated with more recurrence of hepatitis C virus (P = 0.01, HR = 1.6) and primary sclerosing cholangitis (P = 0.03, HR = 2.9). Conclusion: Mismatching at the A locus decreases patient survival in liver transplant recipients, and mismatching at the DR and A loci affects recurrence of autoimmune liver diseases and hepatitis C, respectively.

AB - A perfect or nearly perfect human leukocyte antigen (HLA) match has been associated with better immediate and long-term survival of diseased donor kidney transplants. However, the effect of HLA matching for hepatic allografts remains poorly defined. Using data from the National Institutes of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database, we investigated the association between HLA mismatches and hepatic allograft survival, disease recurrence, and immunosuppression interactions. A, B, and DR loci were used to calculate total mismatch scores of 0 (no mismatches in any loci) to 6 (mismatches in all loci). Seven hundred ninety-nine adults (male, 55%; fcmale, 45%) underwent 883 liver transplants. The 10-year graft survival according to total mismatch score was as follows: 0-2, 60%; 3-4, 54%; and 5-6, 57%. There was a negative effect of mismatching at the A locus on patient survival, with shorter survival for patients with 1 or 2 mismatches compared with 0 mismatches [P = 0.05, hazard ratio (HR) = 1.6]. Patients on tacrolimus with 1 or 2 mismatches at B or DR loci appeared to have increased rates of patient and graft survival compared to patients with 0 mismatches, with the appearance of a protective effect of tacrolimus (HR = 0.67). The cffect of HLA mismatching was more pronounced on certain disease recurrences. DR-locus mismatch increased recurrence of autoimmune hepatitis (P = 0.01, HR = 4.2) and primary biliary cirrhosis (P = 0.04, HR = 2). Mismatch in the A locus was associated with more recurrence of hepatitis C virus (P = 0.01, HR = 1.6) and primary sclerosing cholangitis (P = 0.03, HR = 2.9). Conclusion: Mismatching at the A locus decreases patient survival in liver transplant recipients, and mismatching at the DR and A loci affects recurrence of autoimmune liver diseases and hepatitis C, respectively.

UR - http://www.scopus.com/inward/record.url?scp=51349144887&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=51349144887&partnerID=8YFLogxK

U2 - 10.1002/hep.22435

DO - 10.1002/hep.22435

M3 - Article

VL - 48

SP - 878

EP - 888

JO - Hepatology

JF - Hepatology

SN - 0270-9139

IS - 3

ER -